Skip to main content
U.S. flag

An official website of the United States government

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Cancer, Trauma, and Stroke Imaging Biomarkers are Changing Them All

Cancer and Biomarkers Illustration
Credit: David Bolinsky/XVIVO Scientific Animation, Copyright 2004

Presenter: Michael W. Vannier, M.D., Diagnostic Radiology Department, University of Chicago Medical Center

You might think that imaging biomarkers are the holy grail of clinical medicine or that some advocates have overstated their potential. But, despite a conspicuous lack of standards, balkanization of specialty medicine, a faltering economy, and some initial missteps, imaging biomarkers are fundamental to achieving the promise of personalized medicine. The need for imaging biomarkers arises from an aging population, cost concerns, idiosyncratic effects of drugs, and technological opportunities. We could move a lot faster if a few impediments were addressed. Time is not on our side, so action is needed sooner than later.

Anyone outside NIST wishing to attend must be sponsored by a NIST employee and receive a visitor badge. For more information, call Kum J. Ham at 301-975-4203.

Colloquia are videotaped and available in the NIST Research Library.

Created October 22, 2009, Updated December 30, 2016